Dopamine, 6-hydroxydopamine, iron, and dioxygen - Their mutual interactions and possible implication in the development of Parkinson's disease

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1316, Issue 3, 1996, Pages 160-168

  Linert, Wolfgang ^a   Herlinger, Erwin ^a   Jameson, Reginald F ^b   Kienzl, Elizabeth ^c   Jellinger, Kurt ^c   Youdim, Moussa B H ^d  

^a VIENNA UNIVERSITY OF TECHNOLOGY   (Austria)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c GENERAL HOSPITAL LINZ   (Austria)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

6 Hydroxydopamine; Dopamine; Fenton's reagent; Iron(II); Iron(III); Manganese(II); Nicotine; Parkinson's disease

Indexed keywords

5 HYDROXYDOPAMINE; DOPAMINE; IRON; MANGANESE; METAL ION; OXIDOPAMINE;

ARTICLE; AUTOOXIDATION; CATALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; OXIDATION; PARKINSON DISEASE; PRIORITY JOURNAL; REACTION ANALYSIS;

EID: 0030598917     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/0925-4439(96)00020-8     Document Type: Article

References (47)

1. [1] Kiss, T. and Gergely, A. (1979) Inorg. Chim. Acta 36, 31-36.
2. [2] Linert, W., Jameson, R.F. and Herlinger, E. (1991) Inorg. Chim. Acta 187, 239-247.
3. [3] Linert, W., Herlinger, E. and Jameson, R.F. (1993) J. Chem. Soc. Perkin Trans. II, 2435-2439.
4. [4] Jameson, R.F. and Kiss, T. (1986) J. Chem. Soc. Dalton Trans., 1833-1838.
5. [5] Hirsch, B.C. (1992) Ann. Neurol. 32, 88-93: Kastner, A., Hirsch, B.C., Lejeune, O., Javoy-Agid, F., Rascol, O. and Agid, Y. (1992) J. Neurochem. 59, 1080-1089.
6. [5] Hirsch, B.C. (1992) Ann. Neurol. 32, 88-93: Kastner, A., Hirsch, B.C., Lejeune, O., Javoy-Agid, F., Rascol, O. and Agid, Y. (1992) J. Neurochem. 59, 1080-1089.
7. [6] Fearnley, J.M. and Lees, A.J., Brain (1991) 114, 2289-2301.
8. [7] Enochs W.S., Sarna T., Zecca L., Riley P.A. and Swartz H.M. (1994) J. Neural Transm. [P-D Sect.] 7, 83-100.
9. [8] Ogawa, N., Edamatsu R., Mizukawa K., Asanuma M., Kohno M. and Mori A. (1993) Adv. Neurol., 242-250.
10. [9] Alvord, E.D., Forna, L., Kusske, J.A., Kaufmann, P.J., Rhodes, J.S. and Goetowski, C.R. (1974) Adv. Neurol., 5, 175-193.
11. [10] Sengstock, G.J., Olanow, C.W., Dunn, A.J. and Arendash, G.W (1992) Brain Res. Bull., 645-649.
12. [11] P. Jenner (1991) Acta Neurol. Scand. 84 (suppl. 136), 6-15.
13. [12] Riederer, P., Dirr A., Goetz, M., Sofie, E., Jellinger, K. and Youdim, M.B.H. (1992) Ann. Neurol. 32, 101-104.
14. [13] Youdim, M.B.H., Ben-Schachar, D. and Riederer, P. (1993) Mov. Disord. 8, 1-12.
15. [14] Ben-Schachar, D., Riederer, P. and Youdim, M.B.H. (1991) J. Neurochem. 57, 1609-1614.
16. [15] Thomas, C.E. and Aust, S.D. (1986) J. Biol. Chem, 261, 13064-13070.
17. [16] Herlinger, E., Jameson, R.F. and Linert, W. (1995) J. Chem. Soc. Perkin Trans. II, 259-263.
18. [17] Linert, W., Herlinger, E., Jameson, R.F., Kienzl, E. and Jellinger, K. (1995) in Current Trends in Coordination Chemistry, (Ondrejovic. G. and Sirota, A., eds.), Slovak Techn. Univ. Press, Bratislava, 373-378.
19. [18] Jellinger, K., Linert, W., Kienzl, E., Herlinger, E. and Youdim, M.B.H. (1995) J. Neural Transm. 45 (Suppl.), 297-314.
20. [19] Graham, D.G. (1978) Mol. Pharmacol. 14, 633-643.
21. [20] Kågedahl, B. and Goldstein, D.S. (1988) J. Chromatogr. 429, 177-233.
22. [21] Michel, P.P., Vyas, S. and Agid, Y. (1992) J. Neurochem. 59, 118-127.
23. [22] Sofic, E., Paulus, W., Jellinger, K., Riederer, P. and Youdim, M.B.H. (1991) J. Neurochem. 56, 978-982.
24. [23] Jellinger K., Kienzl, E., Rumplmair, G., Paulus, W., Riederer, P., Sofic, E., Ben Schachar, D. and Youdim, M.B.H. (1993) Adv. Neurol. 60, 267-272.
25. [24] Das, K.C., Abramson, M.B. and Katzman, R. (1978) J. Neurochem. 30, 601-605.
26. [25] MacArthur, C.G. (1916) J. Phys. Chem. 20, 495-502.
27. [26] Ferradini, C. and Pucheault, J. (1983), Biologie de l'Action des Rayonnements Ionisants, Masson, Paris.
28. [27] Misra, H.P. and Fridovich, I. (1972) J. Biol. Chem., 247, 3170-3175.
29. [28] Hawley, M.D., Tatawawadi, S.V., Piekarski, S. and Adams, R.N. (1967) J. Am. Chem. Soc. 89, 447-450.
30. [29] Halliwell, B. (1987) FASEB J. 1, 358-364.
31. [30] Youdim, M.B.H., Ben-Schachar, D. and Riederer, P. (1990) J. Neural Transm. 32 (suppl.), 239-248.
32. [31] Donaldson, J. and Barbeau, A. (1985) Neurol. Neurobiol. 15, 259-285.
33. [32] Graham, D.G. (1984) Neurotoxicology 5, 83-96.
34. [33] Herlinger, E. and Jameson, R.F. (1995) J. Inorg. Biochem. 59, 622.
35. [34] Swartz, H.M., Sarna, T. and Zecca, L. (1992) Ann. Neurol. 32 (suppl.), S69-S75.
36. [35] Slivka, A. and Cohen, G. (1985) J. Biol. Chem. 280, 15468-15472.
37. [36] Morrison, M.E. and Cohen, G. (1983) Biochemistry 22, 5465-5467.
38. [37] Herlinger, E., Jameson, R.F. and Linert, W. (1995) J. Inorg. Biochem. 59, 280.
39. [38] Monteiro, H.P. and Winterbourn, C.C. (1989) Biochem. Pharmacol. 38, 4177-4182.
40. [39] Kienzl, E., Linert, W., Jellinger, K., Puchinger, L., Stachelberger, H. and Jameson, R.F. (1995) J. Neurol. Sci. (suppl.), in press.
41. [40] Oestreicher, E., Sengstock. G.J., Riederer, P., Olanow, C.W., Dunn, A.J. and Arendash, G.W. (1994) Brain Res. 660, 8-18.
42. [41] Mochizuki, H., Imai, H., Endo, K., Yokomizo, K., Murata, Y., Hattori, N. and Mizuno, Y. (1994) Neurosci. Lett. 168, 251-253.
43. [42] Bradley, M.F.B., Hyman, T. and Koroshetz, W. (1993) TINS, 16, 125-131.
44. [43] Andrew, R., Watson, D.G., Best, S.A., Midgley, J.M., Wenlong, H. and Petty, R.K.H. (1993) Neurochem. Res. 18, 1175-1177.
45. [44] Van Duijn, C.M. and Hofman, A. (1991) Br. Med. J. 302, 1491-1494.
46. [45] Grandinetti, A., Morens, D.M., Reed, D. and MacEachern, D. (1994) Am. J. Epidemiol. 139, 1129-1138.
47. [46] Morens, D.M., Grandinetti, A., Reed, D., White, L.R. and Ross, G.W. (1995) Neurology 45, 1041-1051.